Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer

Eur Respir J. 2011 Nov;38(5):1228-30. doi: 10.1183/09031936.00008411.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Squamous Cell / drug therapy*
  • ErbB Receptors / antagonists & inhibitors
  • Erlotinib Hydrochloride
  • Granuloma, Pyogenic / chemically induced*
  • Granuloma, Pyogenic / pathology
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Tracheal Diseases / chemically induced*
  • Tracheal Diseases / pathology

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors